JP2009506122A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009506122A5 JP2009506122A5 JP2008529207A JP2008529207A JP2009506122A5 JP 2009506122 A5 JP2009506122 A5 JP 2009506122A5 JP 2008529207 A JP2008529207 A JP 2008529207A JP 2008529207 A JP2008529207 A JP 2008529207A JP 2009506122 A5 JP2009506122 A5 JP 2009506122A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- activity
- oligodeoxynucleotide
- expression
- cxcl16
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71354705P | 2005-08-31 | 2005-08-31 | |
| US60/713,547 | 2005-08-31 | ||
| PCT/US2006/033774 WO2007027718A1 (en) | 2005-08-31 | 2006-08-28 | Methods of altering an immune response induced by cpg oligodeoxynucleotides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009506122A JP2009506122A (ja) | 2009-02-12 |
| JP2009506122A5 true JP2009506122A5 (https=) | 2009-08-13 |
| JP5481068B2 JP5481068B2 (ja) | 2014-04-23 |
Family
ID=37606913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008529207A Active JP5481068B2 (ja) | 2005-08-31 | 2006-08-28 | ＣｐＧオリゴデオキシヌクレオチドによって誘発される免疫応答を変化させる方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7892569B2 (https=) |
| EP (1) | EP1929014B1 (https=) |
| JP (1) | JP5481068B2 (https=) |
| AU (1) | AU2006284889B2 (https=) |
| CA (1) | CA2620582C (https=) |
| WO (1) | WO2007027718A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US20030026782A1 (en) * | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
| EP1176966B1 (en) * | 1999-04-12 | 2013-04-03 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Oligodeoxynucleotide and its use to induce an immune response |
| US6977245B2 (en) | 1999-04-12 | 2005-12-20 | The United States Of America As Represented By The Department Of Health And Human Services | Oligodeoxynucleotide and its use to induce an immune response |
| AU2001227889A1 (en) * | 2000-01-14 | 2001-07-24 | The United States of America, represented by The Secretary, Department of Health & Human Services | Oligodeoxynucleotide and its use to induce an immune response |
| AU2004275876B2 (en) * | 2003-09-25 | 2011-03-31 | Coley Pharmaceutical Gmbh | Nucleic acid-lipophilic conjugates |
| SI2759306T1 (sl) * | 2008-12-09 | 2016-05-31 | Coley Pharmaceutical Group, Inc. | Imunostimulacijski oligonukleotidi |
| US20100233270A1 (en) | 2009-01-08 | 2010-09-16 | Northwestern University | Delivery of Oligonucleotide-Functionalized Nanoparticles |
| CN103800906B (zh) | 2009-03-25 | 2017-09-22 | 德克萨斯大学系统董事会 | 用于刺激哺乳动物对病原体的先天免疫抵抗力的组合物 |
| WO2012005229A1 (ja) | 2010-07-08 | 2012-01-12 | 科研製薬株式会社 | Ｎ－ヒドロキシホルムアミド誘導体およびそれを含有する医薬 |
| CN103555726B (zh) * | 2013-10-14 | 2015-05-13 | 中国科学院海洋研究所 | 一种含有未甲基化CpG的DNA序列(CpG-DNA)及其应用 |
| TR201908550T4 (tr) | 2014-06-04 | 2019-07-22 | Exicure Inc | Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi. |
| WO2016044839A2 (en) | 2014-09-19 | 2016-03-24 | The Board Of Regents Of The University Of Texas System | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds |
| US11696954B2 (en) * | 2017-04-28 | 2023-07-11 | Exicure Operating Company | Synthesis of spherical nucleic acids using lipophilic moieties |
| WO2019160866A2 (en) | 2018-02-13 | 2019-08-22 | Checkmate Pharmaceuticals, Inc. | Compositions and methods for tumor immunotherapy |
| BR112020020479A2 (pt) | 2018-04-09 | 2021-01-12 | Checkmate Pharmaceuticals | Empacotamento de oligonucleotídeos em partículas similares a vírus |
| EP4637788A1 (en) | 2022-12-19 | 2025-10-29 | Six Therapeutics Inc. | Compositions and methods of using cpg oligonucleotides |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02138868A (ja) * | 1988-11-18 | 1990-05-28 | Eisai Co Ltd | 男性不妊症の診断試薬 |
| CA2328602A1 (en) | 1998-05-06 | 1999-11-11 | University Of Iowa Research Foundation | Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| EP1176966B1 (en) | 1999-04-12 | 2013-04-03 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Oligodeoxynucleotide and its use to induce an immune response |
| AU783118B2 (en) * | 1999-09-27 | 2005-09-29 | Coley Pharmaceutical Gmbh | Methods related to immunostimulatory nucleic acid-induced interferon |
-
2006
- 2006-08-28 CA CA2620582A patent/CA2620582C/en not_active Expired - Fee Related
- 2006-08-28 US US12/065,085 patent/US7892569B2/en not_active Expired - Fee Related
- 2006-08-28 JP JP2008529207A patent/JP5481068B2/ja active Active
- 2006-08-28 WO PCT/US2006/033774 patent/WO2007027718A1/en not_active Ceased
- 2006-08-28 AU AU2006284889A patent/AU2006284889B2/en not_active Ceased
- 2006-08-28 EP EP06813920.3A patent/EP1929014B1/en not_active Ceased
-
2011
- 2011-01-12 US US13/005,488 patent/US8470342B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009506122A5 (https=) | ||
| JP2014511686A5 (https=) | ||
| JP2009511034A5 (https=) | ||
| IL300119A (en) | Oligonucleotides to induce paternal UBE3A expression | |
| JP2008523157A5 (https=) | ||
| JP2021531022A5 (https=) | ||
| JP2017536119A5 (https=) | ||
| JP2009532392A5 (https=) | ||
| JP2016116520A5 (https=) | ||
| RU2014117018A (ru) | Аптамер против ngf и его применение | |
| JP2012136542A5 (https=) | ||
| JP2016522674A5 (https=) | ||
| JP2015523853A5 (https=) | ||
| WO2011142798A3 (en) | Methods of preparing targeted aptamer prodrugs | |
| JP2015528449A5 (https=) | ||
| JP2013537905A5 (https=) | ||
| JP2015518712A5 (https=) | ||
| JP2008526876A5 (https=) | ||
| JP2018530530A5 (https=) | ||
| NZ599237A (en) | Sirna compounds comprising terminal substitutions | |
| JP2009219504A5 (https=) | ||
| WO2007134014A3 (en) | Compounds and methods for modulating expression of gcgr | |
| JP2013510561A5 (https=) | ||
| JP2015518711A5 (https=) | ||
| CA2520541A1 (en) | Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field |